Redeye: Proact - Steady as Expected
Redeye retains its positive view of Proact following a solid Q4 report with EBITA matching our forecast. While the organic growth in recurring revenues remained solid at 9% y/y, the quarter’s highlight was the record-high intake of new cloud contracts. We raise our Base Case slightly despite leaving our forecasts roughly unchanged.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/